MedTrace Logo

Safety and Clinical Effectiveness of A3 SVF in Osteoarthritis

NCT01947348 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-09-04

No results posted yet for this study

Summary

To purpose of this study is to determine if treatment with SVF (Stromal Vascular Fraction) has an effect on pain and inflammation associated with Osteoarthritis.

Conditions

Interventions

PROCEDURE

treatment with A3 SVF

Treatment interarticular and IV with A3 SVF

Sponsors & Collaborators

  • Institute of Regenerative and Cellular Medicine

    lead INDUSTRY

Principal Investigators

  • Barbara Krutchkoff · Institute of Regenerative and Cellular Medicine

  • John Huh, MD · ICMS

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01947348 on ClinicalTrials.gov